Profound Medical Corp.PROFNASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank56
Year-over-Year Change
Year-over-year operating income growth rate
Latest
15.28%
↑ 119% vs avg
Percentile
P56
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
-78.64%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 15.28% |
| Q3 2025 | 36.16% |
| Q2 2025 | -23.64% |
| Q1 2025 | 86.46% |
| Q4 2024 | -778.54% |
| Q3 2024 | 255.03% |
| Q2 2024 | 0.46% |
| Q1 2024 | 87.74% |
| Q4 2023 | -879.29% |
| Q3 2023 | -201.93% |
| Q2 2023 | 193.99% |
| Q1 2023 | 90.88% |
| Q4 2022 | -759.92% |
| Q3 2022 | 247.47% |
| Q2 2022 | -184.59% |
| Q1 2022 | 114.18% |
| Q4 2021 | -767.32% |
| Q3 2021 | 252.24% |
| Q2 2021 | -176.63% |
| Q1 2021 | 119.78% |
| Q4 2020 | -712.08% |
| Q3 2020 | -30.51% |
| Q2 2020 | 19.13% |
| Q1 2020 | -214.14% |
| Q4 2019 | -6.84% |
| Q3 2019 | 207.46% |
| Q2 2019 | -109.30% |
| Q1 2019 | 29.71% |
| Q4 2018 | 27.67% |
| Q3 2018 | 6.09% |
| Q2 2018 | -19.20% |
| Q1 2018 | 17.31% |
| Q4 2017 | 11.09% |
| Q3 2017 | -72.08% |
| Q2 2017 | 26.92% |
| Q1 2017 | 19.82% |
| Q4 2016 | -27.74% |
| Q3 2016 | -10.20% |
| Q2 2016 | 4.80% |
| Q1 2016 | -41.33% |